Skip to content

The Effect of Dry Needling on Muscle Stiffness, Gait, Motion, and Strength in Healthy Individuals With Trigger Points

The Effect of Dry Needling on Muscle Stiffness, Gait, Motion, and Strength in Healthy Individuals With Latent Trigger Points

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03689283
Enrollment
102
Registered
2018-09-28
Start date
2018-10-25
Completion date
2020-01-21
Last updated
2020-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Trigger Point Pain, Myofascial

Brief summary

This study would be the first study to assess the immediate effects of dry needling of latent trigger points of the gastrocnemius muscle on muscle stiffness, gait, range of motion, and strength. The study has the potential to demonstrate that dry needling may have immediate effects on mechanical properties of muscle and may thus guide future treatment for individuals with changes in muscle tissue secondary to pain and/or injury.

Detailed description

Participants will complete the following tests: muscle stiffness testing in both a relaxed and contracted position, GAITRite for spatial and temporal gait characteristics, the Ankle Lunge Test (ALT) to assess range of motion, and calf strength using a dynamometer. Subjects will then receive treatment according to which group they are randomized. Muscle stiffness, gait, motion and strength will be reassessed immediately following treatment at the first session. Four to10 days later, participants will complete the same tests and measures prior to treatment being administered a second time. Another 4-10 days after the second session, participants will complete the tests and measures one final time.

Interventions

OTHERDry Needling

Individuals randomized to the Dry Needling Group will receive dry needling to latent trigger points of the gastrocnemius muscle

OTHERSham Dry Needlling

Individuals randomized to the Control group will receive sham needling to the gastrocnemius muscle

Sponsors

Regis University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

Participants will be blinded to group allocation. Participants in the control group will receive sham needling.

Intervention model description

Prospective randomized controlled trial

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

1. Age 18-50 years 2. Able to read and speak sufficient English to complete consent form 3. Symmetrical gait pattern demonstrated through observation 4. Presence of latent trigger point in gastrocnemius muscle

Exclusion criteria

1. Any prior foot/ankle surgery, deformity, or injury on the which would affect strength of the gastrocnemius 2. Any prior acupuncture or dry needling within the past month 3. History of systemic disorder in which dry needling would be contraindicated (i.e. bleeding disorders or anticoagulant medication use) 4. Have fractures of the spine, hip, or knee that would likely affect their weight bearing or gait 5. Restrictions in plantar flexion range of motion which would inhibit performing a heel raise 6. No specific calf injury in the past 6 months 7. Participants known or thought to be pregnant

Design outcomes

Primary

MeasureTime frameDescription
MyotonPRO2 yearsMuscle stiffness will be measured in both a resting and contracted state utilizing this non-invasive device

Secondary

MeasureTime frameDescription
Knee to wall2 yearsGroup by time differences will be assessed for talocrural motion (knee to wall)
GAITRite2 yearsGroup by time differences will be assessed for gait variables (utilizing the GAITRite 6-meter mat)
Handheld dynamometer2 yearsGroup by time differences will be assessed for strength of the gastrosoleus complex (utilizing a handheld dynamometer)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026